With respect to the prognostic significance of VMP1, GBM patients with high VMP1 expression were found to have a shorter overall survival duration in all three cohorts (TCGA, p = 0.034; CGGA, p = 0.039; our in‐house cohort, p = 0.0005) (Figure 1G–I and Figure S1). This evidence concerns the gene VMP1 and glioblastoma.